Physician profile
John P Scally
NPI 1508952318
$4,584.76
in general payments reported to CMS, 2019-2025
9 companies · $1,498 in 2025
The $1,498 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.94 · 2020: $42.50 · 2021: $189 · 2022: $357 · 2023: $193 · 2024: $2,260 · 2025: $1,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,044 · Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,044.20 |
| Food and Beverage | $906.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,694.01 | 2021-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $1,359.20 | 2021-2024 | Pascal |
| Boston Scientific Corporation | $155.21 | 2019-2023 | Watchman Access System |
| Amgen INC. | $154.53 | 2023-2024 | Repatha |
| Abiomed | $139.39 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.96 | 2020 | |
| Lantheus Medical Imaging, INC. | $25.02 | 2024 | |
| Medtronic Vascular, INC. | $16.54 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.